Toshiba strikes PACS deal with Agfa

Article

Toshiba America Medical Systems and Agfa have signed a value-addedreseller agreement in which Toshiba will be able to sell Agfa'sImpax PACS line in situations where it is also selling multimodalityequipment. The nonexclusive deal finally gives Tustin,

Toshiba America Medical Systems and Agfa have signed a value-addedreseller agreement in which Toshiba will be able to sell Agfa'sImpax PACS line in situations where it is also selling multimodalityequipment. The nonexclusive deal finally gives Tustin, CA-basedToshiba a PACS line to compete with those of its multimodalitycompetitors.

Toshiba plans to use the deal to leverage sales of imagingequipment, rather than become a PACS vendor, according to LeslieFerrini, manager of Toshiba's connectivity systems group, whichwas formed earlier this year. The agreement is restricted to theU.S. at present.

For Agfa, the relationship gives it another distribution channelfor the Impax line, according to John Glass, Agfa's senior vicepresident of technical imaging. Toshiba becomes the RidgefieldPark, NJ, company's second multimodality OEM, following a dealwith Elscint signed last year (SCAN 11/22/95). Agfa will probablypursue more OEM deals, Glass said.

Toshiba and Agfa are collaborating on a PACS installation commissionedby Genesys Hospital System. Genesys is building a new facilityin Grand Blanc, MI, called Health Park, which will be filmlesswhen it opens in February. Last month's agreement formalizes therelationship that began at Genesys, according to Ferrini.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.